tiprankstipranks
Trending News
More News >
BioNano Genomics Inc (GB:0A4K)
LSE:0A4K
UK Market

BioNano Genomics (0A4K) Financial Statements

Compare
1 Followers

BioNano Genomics Financial Overview

BioNano Genomics's market cap is currently $11.60M. The company's EPS TTM is $; its P/E ratio is ―; BioNano Genomics is scheduled to report earnings on May 14, 2025, and the estimated EPS forecast is $-2.31. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 30.78M$ 36.12M$ 27.80M$ 17.98M$ 8.50M
Gross Profit$ 380.00K$ 9.57M$ 5.95M$ 3.87M$ 2.77M
Operating Income$ -103.98M$ -215.25M$ -131.70M$ -77.10M$ -38.55M
EBITDA$ -97.47M$ -213.60M$ -120.31M$ -73.86M$ -37.08M
Net Income$ -112.02M$ -232.49M$ -132.60M$ -72.44M$ -41.14M
Balance Sheet
Cash & Short-Term Investments$ 9.47M$ 101.89M$ 113.19M$ 250.61M$ 38.45M
Total Assets$ 76.67M$ 214.40M$ 307.50M$ 377.10M$ 60.45M
Total Debt$ 27.30M$ 79.41M$ 11.67M$ 10.70M$ 16.33M
Net Debt$ 18.12M$ 61.47M$ 6.58M$ -13.88M$ -22.12M
Total Liabilities$ 41.30M$ 118.25M$ 58.10M$ 39.98M$ 25.37M
Stockholders' Equity$ 35.38M$ 96.16M$ 249.40M$ 337.12M$ 35.08M
Cash Flow
Free Cash Flow$ -69.03M$ -126.87M$ -128.12M$ -73.39M$ -38.31M
Operating Cash Flow$ -68.92M$ -125.18M$ -124.82M$ -71.93M$ -38.31M
Investing Cash Flow$ 73.84M$ 24.16M$ 82.77M$ -278.06M$ -2.45M
Financing Cash Flow$ -13.69M$ 113.81M$ 23.01M$ 336.11M$ 61.90M
Currency in USD

BioNano Genomics Earnings and Revenue History

BioNano Genomics Debt to Assets

BioNano Genomics Cash Flow

BioNano Genomics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis